MedPath

DAIICHI SANKYO HONG KONG LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

PPB:15

Drug Approvals

VANFLYTA TABLETS 26.5MG

Approval Date
Apr 25, 2025
PPB

VANFLYTA TABLETS 17.7MG

Approval Date
Apr 25, 2025
PPB

NUSTENDI TABLETS 180MG/10MG

Approval Date
Apr 28, 2023
PPB

NILEMDO TABLETS 180MG

Approval Date
Apr 28, 2023
PPB

ENHERTU POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG

Approval Date
Dec 14, 2021
PPB

LIXIANA TABLETS 30MG

Approval Date
May 31, 2016
PPB

LIXIANA TABLETS 15MG

Approval Date
May 31, 2016
PPB

LIXIANA TABLETS 60MG

Approval Date
May 31, 2016
PPB

CRAVIT TAB 250MG

Approval Date
Oct 14, 2003
PPB

CRAVIT IV SOLUTION FOR INFUSION 5MG/ML

Approval Date
Aug 23, 1999
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.